16/06/2026

Evaluation of the Research Institute for Medical Innovation (RIMI)

The text on this page was automatically translated and hence may differ from the original. No rights can be derived from this translation.

For the evaluation of the Research Institute for Medical Innovation (RIMI, the research institute of Radboudumc), an international committee was deployed within the framework of the national Strategy Evaluation Protocol (SEP). A SEP evaluation is the standard method used to periodically assess Dutch research institutes on scientific quality, societal relevance, and future-proofing. In this case, it was an exceptionally extensive evaluation, where both the institute as a whole and 48 underlying research programmes were assessed by a committee of 21 scientists. The committee concludes that RIMI delivers strong research results with visible international impact and a clear contribution to societal issues in healthcare. At the same time, the committee provides recommendations for the future, particularly focusing on making strategic choices for research programmes and staff development. Dialogic acted as the secretary of the evaluation committee in this process and supported the preparation to reporting stages. This evaluation underscores our experience in guiding extensive and complex evaluation processes in an international context. Drawing from this experience, we are happy to collaborate with organisations considering similar ventures.